Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Brahmajee Nallamothu

Interventional Cardiology · UMHS

View

Dr. Mohamad Adnan Alkhouli

Interventional Cardiology · Mayo Clinic College of Medicine

View

Dr. Ajay Kirtane

Interventional Cardiology · CUIMC

View

Dr. Manesh Patel

Interventional Cardiology · Duke University

View

Dr. Deepak Bhatt

Interventional Cardiology · Mount Sinai

View

Dr. Sunil Rao

Interventional Cardiology · NYU Langone

View

Dr. Alexander Fanaroff

Interventional Cardiology · UPenn

View

Dr. James Tcheng

Interventional Cardiology · Duke

View

Dr. Pinak Shah

Interventional Cardiology · PHS

View

Dr. Dorairaj Prabhakaran

General Cardiology

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JNDr. Johny Nicolas

    Dr. Johny Nicolas

    Cardiology · Interventional Cardiology
    Icahn School of Medicine at Mount Sinai
    johny

    Research

    Major Bleeding Risk Assessment With Atrial Fibrillation Post-TAVR: The HARHP Score Results From ENVISAGE-TAVI AF

    2026

    Via JACC Cardiovasc Interv

    Research

    Comparative Performance of Machine Learning and Traditional Risk Scores in Predicting Adverse Events After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation

    2026

    Via Am J Cardiol

    Research

    Clinical Differences and Disparities Among Men and Women With Acute Myocardial Infarction-Related Cardiogenic Shock Undergoing Percutaneous Coronary Intervention

    2026

    Via Am J Cardiol

    Research

    Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impact

    2026

    Via Eur Heart J

    Research

    Equal Prevalence, Unequal Care

    2026

    Via J Am Coll Cardiol

    Research

    Edoxaban Dose Adjustment and Age-Associated Outcomes in Patients With Atrial Fibrillation Post-Transcatheter Aortic Valve Replacement

    2025

    Via JACC Adv

    Research

    Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trial

    2025

    Via American Heart Journal

    Research

    Treatment of Additional Vessels During Percutaneous Coronary Intervention for Unprotected Left Main Disease: Insights From a Large Prospective Registry

    2025

    Via The American Journal of Cardiology

    Research

    Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular disease

    2025

    Via European Journal of Preventive Cardiology

    Research

    Inflammation and Contrast-Associated Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention

    2025

    Via The American Journal of Cardiology

    May 15, 2025Clinical Trial, Phase III

    Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE-TAVI AF Trial.

    ​

    Written by 1 Roon author & 12 others

    Via The American Heart Association Journals

    Research

    Impact of left ventricular function on outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention

    2025

    Via American Heart Journal

    Research

    Antithrombotic strategies after TAVI in light of cerebral microembolism

    2025

    Via EuroIntervention

    Research

    Timing, indications and transition patterns associated with cangrelor use in patients undergoing PCI

    2025

    Via Journal of Thrombosis and Thrombolysis

    Research

    Impact of Remnant Cholesterol on Cardiovascular Outcomes in Non-Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention

    2025

    Via European Journal of Preventive Cardiology